Preparation in Biological Technology

Caliper Life Sciences Introduces Staccato Protein Workstation for Automated Protein Sample Preparation & Analysis

- Caliper Addresses Key Bottlenecks in Quality by Design Initiative for Protein Therapeutics - HOPKINTON, Mass., June 29 Caliper Life Sciences, Inc. (Nasdaq: CALP ), a leading provider of tools and services for drug discovery and life sciences research, today launched the Staccato Protein W...

Pressure BioSciences, Inc. Releases Novel, PCT-dependent Sample Preparation Kit for Systems Biology Studies

SOUTH EASTON, Mass., Aug. 20 /PRNewswire-FirstCall/ -- Pressure BioSciences, Inc. (Nasdaq: PBIO ) ("PBI" or the "Company") today announced the release for sale of ProteoSolve-SB, a novel, pressure cycling technology ("PCT")-dependent kit for the simultaneous extraction, isolation, and fractio...

Canadian Centre for DNA Barcoding to Participate in Microchip Biotechnologies Early Access Program for Microchip-Based DNA Sample Preparation and Cycle Sequencing

DUBLIN, Calif., April 8, 2008 /PRNewswire/ -- Microchip Biotechnologies, Inc. (MBI) is pleased to announce that the Canadian Centre for DNA Barcoding (CCDB), at the Biodiversity Institute of Ontario, University of Guelph, will be the first participant to join MBI's early access program for the...

Microchip Biotechnologies, Inc. Collaborating With Stanford University on Developing a Front End Microfluidic-Based Sample Preparation System for Pyrosequencing Platforms

DUBLIN, Calif., Feb. 28 /PRNewswire/ -- Microchip Biotechnologies, Inc. (MBI) is collaborating with Stanford University to develop a front-end microfluidic based sample preparation system to generate template libraries for next generation Pyrosequencing. The goal of the project is to automate ...

Nitec Pharma AG Announces Appointments of CEO & CFO in Preparation for Launch of Lodotra(R)

REINACH, Switzerland, September 3 /PRNewswire/ -- Nitec Pharma AG, today announced the appointments of Anders Harfstrand as Chief Executive Officer, and Andrea Buscaglia as Chief Financial Officer. Both executives bring with them a wealth of strategic knowledge and expertise which complement t...

China's Vice Premier, Li Keqiang, Visits Sinovac to Inspect H1N1 Vaccine Production Preparation

BEIJING, June 2 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE Amex: SVA ), a leading developer and provider of vaccines in China, announced today that China's Vice Premier, Li Keqiang, accompanied with State Councilor and Secretary of the State Council, Ma Kai; Head of General Administrati...

New 200 mg Vial for Eloxatin(R) (Oxaliplatin Injection) Offers Greater Convenience and Efficiency of Preparation

BRIDGEWATER, N.J., Aug. 27 /PRNewswire-FirstCall/ -- Sanofi-aventis U.S. launched today a new 200 mg single-use vial of its chemotherapy treatment Eloxatin(R) (oxaliplatin injection) for patients who have adjuvant stage III colon cancer and advanced colorectal cancer, which is expected to offe...

High Throughput Plasmid DNA Preparation Using A Magnetic Bead Kit On An Automated Workstation

James Batchelor, Lynn Jordan, and Ed Alderman Applied Science and Technology Department, Caliper Life Sciences, Inc., Hopkinton, MA 01748 Karen Heins and Olaf Stelling Agencourt Bioscience Corporation, 100 Cummings Center, Suite 107J, Beverly, MA 01915 ...

Sample Preparation Solutions for Cellular Protein Fractionation Poster, Rev A

T Slyker, B Gillece-Castro, M Nguyen, L Sapp, MG Brubacher, and WB Strong Presented by the Authors at The Association of Biomolecular Resource Facilities (ABRF) February 1013, 2003 Denver, Colorado Abstract ...

Commercial Plasmid Preparation Methods Yield DNA With Different Transfection Capabilities

Kathleen A. Maguire-Zeiss, Brandon K. Harv e y, Rita E. Giuliano and H o w a rd J. Federo ff, University of Rochester, Rochester, NY, USA Introduction Transfection efficiency is dependent upon a number of factors, including method of transfection...

Genomic DNA Preparation from RNAlater Preserved Tissues

The following protocol is suitable for 100 mg tissue samples. Mouse kidney, lung, and spleen genomic DNA have been successfully extracted with approximate yields of 70 g DNA per 100 mg tissue. Required Materials ...

Dicer vs. RNase III for Preparation of siRNA Cocktails

Both recombinant human Dicer and Escherichia coli RNase III can be used in vitro to cleave long dsRNA, producing siRNA cocktails that are effective mediators of gene silencing (1-6). Dicer is an endoribo...

High Pure PCR Template Preparation Kit

For isolating genomic nucleic acids for PCR, restriction enzyme analysis, and Southern blotting Catalog Number Pack Size ...

Easy preparation of total RNA from cultured cells with TRIzol and Eppendorf Phase Lock Gel

Christian Bauer, Oliver Klotzsche, and Frank Apostel Christian Bauer, Oliver Klotzsche, CCS Cell Culture Service GmbH, Falkenried 88, D-20251 Hamburg, Germany, Frank Apostel, Eppendorf AG, Germany ...

Sample Preparation for Microinjection

General Comments Microinjection is the loading or transfer of a dissolved substance into a living cell. The microscopic tip of the glass microcapillary has an inner...

InterMune Reports Second Quarter 2009 Financial Results and Business Highlights

...irfenidone, we have made excellent progress on the preparation of our New Drug Application (NDA) for pirfenidone ... associated with the RECAP extension study and the preparation of the NDA and MAA for pirfenidone. General and a... percent, primarily attributed to costs related to preparation for the anticipated commercialization of pirfenido...

Patent Attorney John Rizvi Speaks at FIME International Medical Expo

...This can allow a competitor to "design around" a patented product. John Rizvi has over 14 years of experience focused exclusively on the preparation and prosecution of U.S. and international patent and trademark applications, patent and trademark validity and infringement opinions, licensing, trans...

Mylan Reports Adjusted Diluted EPS of $0.32 for the Quarter Ended June 30, 2009

...any's business; uncertainties and matters beyond the control of management; inherent uncertainties involved in the estimates and judgments used in the preparation of financial statements, and the providing of estimates of financial measures, in accordance with GAAP and related standards. These cautionary stateme...

Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications

... We are also excited to be completing data collection and review of key efficacy endpoints for this novel regenerative medicine product candidate, in preparation for a detailed report of overall safety and efficacy data that we expect to be made around the end of September," stated Christopher J. Reinhard, Chai...

Cell Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock and Warrants

... paying interest on and/or retiring portions of the Company's outstanding debt, funding research and development, preclinical and clinical trials, the preparation and filing of new drug applications and general working capital. Rodman & Renshaw, LLC, a wholly-owned subsidiary of Rodman & Renshaw...

University of Florida Shands Cancer Center Selects OnCore(r) to Support its Collaborative Research Goals

..., the center has arranged resources to make the transition a priority throughout the summer. Work has already begun to clean up the legacy database in preparation for a smooth data migration. The UFSCC will be implementing both the OnCore Clinical Research Management (OnCore-CRM) and the Biospecimen Manageme...

Vasogen Announces Second Quarter 2009 Results

...s", "potential", "continue", "intends", "could", or the negative of such terms or other comparable terminology. We made a number of assumptions in the preparation of these forward-looking statements. You should not place undue reliance on our forward-looking statements, which are subject to a multitude of risks ...

King and Pain Therapeutics Announce REMOXY(R) NDA Update

...s. Such statements involve risks and uncertainties, including, but not limited to, those risks and uncertainties relating to difficulties or delays in preparation and resubmission of the NDA for REMOXY(R) and whether or when the NDA for REMOXY(R) is approved by the FDA. Other important factors that may cause act...

Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa

...wth for an entire week, a single subcutaneous injection of the recommended dose of corifollitropin alfa may replace the first seven injections of rFSH preparation in a COS treatment cycle. The corifollitropin alfa regimen is being developed in a GnRH antagonist protocol. Corifollitropin alfa was filed in the E...

Horizon Therapeutics Names Dr. Jeffrey W. Sherman Executive Vice President and Chief Medical Officer

...hrough the regulatory process," said Timothy P. Walbert, president and chief executive officer of Horizon Therapeutics. "Dr. Sherman will oversee the preparation and submission of the HZT-501 regulatory applications to U.S. and European regulatory authorities, while helping us manage the clinical development of...

Cordex Completes Production of ATPace(TM) Clinical Trial Material

..., Inc. (OTC Bulletin Board: CDXP) announced today that it has successfully completed the production of the ATPace(TM) clinical trial material (CTM) in preparation for planned pivotal clinical trials. The protocol of these clinical trials has been approved by the U.S. Food and Drug Administration (FDA) under the ...

Palkion Selects Novel Oral Development Candidate for the Treatment of Anemia

... high level of enthusiasm as Palkion's candidates have demonstrated benefits and features in terms of efficacy at this early stage of development. In preparation of expedited preclinical development, Palkion has been assembling a team of clinical, regulatory and commercial experts from the pharmaceutical indust...

CSOFT Announces Introduction of L10NPRO 3.0 at 6th Annual Worldwide Summit in Beijing

...chnology. EM will provide engineers with the ability to reuse previous engineering work performed for the same file type, dramatically improving file preparation efficiency and consistency. The other important feature is L10NPRO's EM Editor to edit once a new file type is processed so that the system can automa...

New England Journal of Medicine Study Highlights Need for Rapid, PCR-based Group B Streptococcus (GBS) Testing at Time of Admission for Labor and Delivery

..., producing accurate results in a timely manner with minimal risk of contamination. The GeneXpert System is the only system to combine on-board sample preparation with real-time PCR (polymerase chain reaction) amplification and detection functions for fully integrated and automated nucleic acid analysis. The sys...

CutisPharma, Inc. Receives Verified Accreditation for Wholesale Distributors from the National Association of Boards of Pharmacy for Woburn Facility

...of the pharmaceutical industry. Product line and development efforts initially are focused on providing optimized, more efficient alternatives for the preparation of the nearly 10 million currently compounded prescriptions, by offering FIRST(R) Unit-of-Use Prescription Compounding Kits. Use of these branded comp...

MicroFluidic Systems (MFSI) Receives Patent for Method to Selectively Process Different Biological Cell Types for Analysis.

...roFluidic Systems (MFSI), www.microfluidicsystems.com , was founded in 2001 and is focused on the development of microfluidic systems for automated preparation of biological assays. MFSI personnel have been involved with the development of automated DNA-based pathogen detection systems and microfluidics for t...

FDA Appointed Arthritis Advisory Committee Recommends U.S. Food and Drug Administration Approval for KRYSTEXXA(TM) for Refractory Chronic Gout

...statements regarding the efficacy and safety of KRYSTEXXA(TM) (pegloticase), our BLA filing with the FDA, the Advisory Committee, approval of the BLA, preparation for commercialization of KRYSTEXXA, and the market for KRYSTEXXA, are forward-looking statements. These forward-looking statements involve substantial...

Helix BioPharma Announces Q3 2009 Financial Results and Provides Product Development Update

...s in the United States and Europe respectively. Although all activities in preparation for the planned Phase IIb/III trials are progressing, the Company has exper...re associated with the scale-up manufacturing of GMP engineering batches in preparation for clinical trial batch manufacturing. The majority of the Topica...

Frost & Sullivan Recognizes Cisbio Bioassays for Technology Innovation

...ing assay to nearly 1/8th the time usually needed to run a standard radio labeled ligand binding assay. Moreover, it eliminates the steps for membrane preparation or overnight counting for ligand binding. "Further, with the development of its second generation HTRF technology, HTRF Terbium, Cisbio Bioassays...

Xceed Meets HTX/CIHR Grant Milestone: Decreasing Sample-Prep Time From Days to Less Than Eight Hours

...the company continues its commitment to streamlining and speeding up sample preparation even further. Its ultimate goal is to enable researchers to turnaround results from sample preparation through gene-expression analysis in one eight-hour shift. "The analys...

Genomatica Produces Pure BDO From Natural Sugars

...m start to finish. Genomatica is now refining the complete process to improve the cost-efficiency of every step of the process, from raw material preparation and fermentation to separation and purification. When the demonstration plant validation is complete, Genomatica will then commercialize the process ...

Celsense, Inc Receives NIH Grant to Translate Cell Imaging Technology for Clinical Use

...on of the Cell Sense reagent has been formulated by Celsense, Inc. and is currently being subjected to mandatory in vitro and animal safety studies in preparation for human trials. To conduct this project, Celsense has partnered with academia, including scientists at Carnegie Mellon University, where the ima...

Sinobiopharma Applies For Two Chinese Patents For Cisatracurium Besylate

...ion. The Company has also applied to SIPO for a Chinese patent for the preparation for separating and purifying Cisatracurim besylate through HPLC (Application Number 200910028198.3; "The preparation for separating and purifying Cisatracurim besylate through HPLC"). Using th...

Dr. Chris Huber Joins Asymchem Laboratories Inc. as Director of Chemical Development

...eer was spent in Pfizer and legacy companies in process chemistry, with focus on optimization, characterization and validation of Phase 3 processes in preparation for commercial manufacturing of API. As Director of Chemical Development, Dr. Huber will help expand and strengthen Asymchem's pilot scale-up, te...

DOR BioPharma Reports 1st Quarter 2009 Financial Results and Reviews Recent Accomplishments

...0.01 per share, for the first quarter of 2008. This increase was primarily attributed to increased spending of $968,996 in research and development in preparation for the initiation of the confirmatory Phase 3 clinical trial of orBec(R) for the treatment of acute gastrointestinal Graft-versus-Host disease (GI GV...